Zerit

   
Google
 
Web NewDrugInformation.com

Zerit


Drug - Zerit
The trade name of the product as shown on the labeling.

Dosage - FOR SOLUTION; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Stavudine
Multiple ingredients are in alphabetical order.

Strength - 1MG/ML
The potency of the active ingredient(s), Stavudine. May repeat for multiple part products.

Applicant - BRISTOL MYERS SQUIBB
The firm name holding legal responsibility for Zerit. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020413
The FDA assigned number to Zerit. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Zerit. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 6, 1996
The date Zerit was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Zerit. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Zerit is in. Format is RX, OTC, DISCN.

Applicant Full Name - Bristol Myers Squibb Co Pharmaceutical Research Institute
The full name of the firm holding legal responsibility for the new application of Zerit.

Zerit